Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by picktherighton Aug 08, 2019 10:16pm
94 Views
Post# 30009268

ISOL will run soon

ISOL will run soonI’m surprised with the fact that the board members are spreading sooooo much negativity to scare retail investors. There are people like daveknowsbest and PONZIFINDER who are posting tirelessly to bash the stock. To keep the bashing going, the following members respond to them regularly: bruser56, grpition, donniebrasco01, and now capebretongirl. If I were pro ISOL, I will simply ignore those two. However, I think they all might have a common agenda.

ISOL is way under valued and over sold. This is getting ready for a run, the chart is a screaming buy. Even if the financials are bad and have a quarterly sale of 2 million (as claimed by some gurus here), all that has been priced in. The market cap of 25 million is not justifiable. 

Once again, please stand your ground, don’t fall into the scare tactics. Hold on to your shares, $1 per share is closer than it may seem.
Bullboard Posts